Thank you, Matt, and good morning everyone. Our portfolio which totaled $5.1 billion at the end of the quarter has a weighted average risk rating of 2.9 on a five point scale, in line with a 2.9 risk rating at the end of 3Q. During the quarter, no assets experienced a deterioration in risk rating, while the rating of one loan improved. 99.9% of the portfolio was invested in LIBOR-based floating rate loans. As we discussed previously, LIBOR floors provide a net interest income benefit in a declining rate environment. Notably, our 2019 originations, which are both in the early stages of sponsor business plans and have certain prepayment protections had a weighted average LIBOR floor of 2.2%, and on an outstanding principal amount representing approximately 52% of the portfolio. Additionally, approximately half of the portfolio has a LIBOR floor of at least 2.0%. Conversely, almost none of our liabilities have a floor, thus allowing us to benefit from decreased financing costs in a declining rate environment. Turning to our liabilities. We continue to make progress in optimizing our financing, most notably from sources that are non-mark-to-market. As Chris mentioned, in 2019, we increased our overall financing capacity by approximately $1.2 billion which included a new $900 million non-mark-to-market term lending agreement with extension options out the seven years matching the term of the longest underlying asset and features an initial pro rata paydown structure, which preserves our leverage for a period of time. Additionally, we increased the size of our corporate revolving credit facility to $250 million. And finally, subsequent to quarter end, we upsized this revolver by an additional $85 million bringing total capacity to $335 million. All of these initiatives continue to optimize our balance sheet. As of year-end, 72% of our secured financing were non-mark-to-market compared to 60% in 2018 and 13% in 2017. We will continue to evaluate all sources of financing and capital markets options, and we will continue to look at the a note market as a source of matched term, non-mark-to-market, non-recourse asset financing. The attractive cost of these various funding options allows us to compete for the highest quality lending opportunities and secure better credits for KREF. We're still delivering an attractive return to the company. In addition, our liability structure is more durable from a mark-to-market perspective and improves our ability to manage risk and liquidity on the balance sheet. As we have grown our non-mark-to-market financings, we've been willing to finance loans at the low 80% advance rates. As of year-end, our debt-to-equity ratio and total leverage ratio or 1.9 times and 3.5 times respectively. It was another strong quarter and year for KREF. We post it record originations with a growing pipeline. Our portfolio is performing and we continue to make significant progress creating differentiated efficient financing. Before we open the call for your questions, I’ll turn it over to Mostafa to briefly touch on our CECL implementation efforts.